Skip to content

Aquestive Therapeutics, Inc. AQST Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$22M-40.5%
AMP
Amphastar PharmaceuticalsAMPH
$71.5M+56.0%
Regenxbio logo
RegenxbioRGNX
$45.54M-12.6%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$268K-56.4%
Viatris logo
ViatrisVTRS
AptarGroup logo
AptarGroupATR

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s operating lease ROU assets?
Aquestive Therapeutics, Inc. (AQST) reported operating lease ROU assets of $4.47M in Q1 2026.
How has Aquestive Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Aquestive Therapeutics, Inc.'s operating lease ROU assets decreased by 11.5% year-over-year, from $5.05M to $4.47M.
What is the long-term trend for Aquestive Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s operating lease ROU assets has grown at a 6.0% compound annual growth rate (CAGR), from $3.45M to $4.62M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.